CO19 Sintilimab Plus Chemotherapy for First-Line Treatment of Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer (AMNSQNSCLC): A Systematic Literature Review (SLR) and Network Meta-Analysis (NMA)
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.117
https://www.valueinhealthjournal.com/article/S1098-3015(22)00318-7/fulltext
Title :
CO19 Sintilimab Plus Chemotherapy for First-Line Treatment of Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer (AMNSQNSCLC): A Systematic Literature Review (SLR) and Network Meta-Analysis (NMA)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00318-7&doi=10.1016/j.jval.2022.04.117
First page :
Section Title :
Open access? :
No
Section Order :
10093